Wide Ranks

HOWL

Werewolf Therapeutics, Inc.

1.97

Top Statistics
Market Cap 87 M Forward PE -1.48 Revenue Growth 0.00 %
Current Ratio 10.10 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -0.0270 Enterprise / Revenue 0.5140 Price To Sales Trailing12 Months 25.93
Profitability
Profit Margins 0.00 % Operating Margins -1955.35 %
Balance Sheet
Total Cash 122 M Total Cash Per Share 2.76 Total Debt 36 M
Total Debt To Equity 41.15 Current Ratio 10.10 Book Value Per Share 2.04
All Measures
Short Ratio 89.00 % Message Board Id finmb_560735713 Shares Short Prior Month 775986
Return On Equity -0.6156 City Watertown Uuid 07b61817-4b0c-36bb-893c-b622112d893f
Previous Close 1.96 First Trade Date Epoch Utc 1 B Book Value 2.04
Beta 0.4140 Total Debt 36 M Volume 247454
Price To Book 0.9638 Fifty Two Week Low 1.58 Total Cash Per Share 2.76
Total Revenue 3 M Shares Short Previous Month Date 1 B Target Median Price 12.50
Max Age 86400 Recommendation Mean 1.33 Sand P52 Week Change 0.3133
Operating Margins -1955.35 % Target Mean Price 12.00 Net Income To Common -62118000
Short Percent Of Float 0.0496 Implied Shares Outstanding 44 M Trailing Peg Ratio None
Last Fiscal Year End 1 B Average Daily Volume10 Day 539980 Average Volume10days 539980
Total Cash 122 M Next Fiscal Year End 1 B Revenue Per Share 0.0820
Held Percent Insiders 0.0611 Trailing PE 0.0000 Date Short Interest 1 B
Most Recent Quarter 1 B Regular Market Previous Close 1.96 Target Low Price 8.00
Gmt Off Set Milliseconds -18000000 Fifty Day Average 2.21 Open 1.96
Free Cashflow -27666376 State MA Dividend Yield 0.00 %
Return On Assets -0.2616 Time Zone Short Name EST Trailing Eps -1.52
Day Low 1.91 Address1 200 Talcott Ave Shares Outstanding 44 M
Price Hint 4 Target High Price 15.00 Website https://werewolftx.com
52 Week Change -0.1959 Average Volume 691428 Forward Eps -1.82
Recommendation Key strong_buy Compensation As Of Epoch Date 1 B Quick Ratio 989.20 %
Is_sp_500 False Regular Market Day High 2.00 Profit Margins 0.00 %
Debt To Equity 41.15 Fifty Two Week High 8.19 Day High 2.00
Shares Short 1 M Regular Market Open 1.96 Industry Key biotechnology
Earnings Growth 0.00 % Enterprise To Revenue 0.5140 Revenue Growth 0.00 %
Shares Percent Shares Out 0.0294 Operating Cashflow -46521000 Currency USD
Time Zone Full Name America/New_York Market Cap 87 M Is_nasdaq_100 False
Zip 02472 Quote Type EQUITY Industry Biotechnology
Long Name Werewolf Therapeutics, Inc. Regular Market Day Low 1.91 Held Percent Institutions 0.7265
Current Price 1.97 Address2 2nd Floor Enterprise To Ebitda -0.0270
Financial Currency USD Current Ratio 10.10 Industry Disp Biotechnology
Number Of Analyst Opinions 6 Country United States Float Shares 25 M
Two Hundred Day Average 3.72 Enterprise Value 1 M Price To Sales Trailing12 Months 25.93
Forward PE -1.48 Regular Market Volume 247454 Ebitda -64376000
Exchange NMS
Go to Yahoo Finance Go to Seeking Alpha 
Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer.

The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional proinflammatory immune therapies.

Its lead product candidates are WTX-124, a conditionally activated Interleukin-2 INDUKINE molecule that is in Phase I/Ib clinical trial for the treatment of advanced or metastatic solid tumors; and WTX-330, a conditionally activated Interleukin-12 INDUKINE molecule, which is in Phase I clinical trial for the treatment of advanced or metastatic solid tumors and lymphoma.

The company is also developing JZP898, a conditionally activated interferon alpha INDUKINE molecule for the treatment of cancer; and WTX-712, an activated Interleukin-21(IL-21) and WTX-518, an activated IL-18 (IL-18) INDUKINE molecule for the treatment of cancer.

Werewolf Therapeutics, Inc. was incorporated in 2017 and is headquartered in Watertown, Massachusetts.